{"status":"success","data":{"title":"Atrial Fibrillation and Anticoagulation","slug":"atrial-fibrillation","tags":["aspirin","warfarin"],"collection":["cardiovascular"],"content":"\n# Atrial Fibrillation and Anticoagulation\n\n-   Anticoagulation goal with <span class=\"drug\">warfarin</span>: INR 2-3\n-   If age &lt; 60 years and zero risk factors: No anticoagulation b/c low risk for CVA \n\n**Deciding on whether to anticoagulate with aspirin or warfarin:**\n\n## Weak Risk Factors\n\n- Female gender    \n- Age 65-74         \n- CAD               \n- Thyrotoxicosis\n\n**Treatment**\n\n- <span class=\"drug\">warfarin</span> or <span class=\"drug\">warfarin</span>\n\n## Moderate Risk Factors\n\n- Age &gt; 75            \n- HTN                     \n- Heart failure           \n- LVEF ≤ 35%              \n- DM  \n\n**Treatment**\n\n- 1 Risk factor: <span class=\"drug\">aspirin</span> or <span class=\"drug\">warfarin</span>\n- &gt; 1 Risk factor: <span class=\"drug\">warfarin</span>\n\n## High Risk Factors\n\n- Prior CVA        \n- Prior TIA         \n- Embolism          \n- Mitral stenosis   \n- Mech heart valve\n\n**Treatment**\n\n- <span class=\"drug\">warfarin</span>\n\n([AHA/ACC/ESC 2006 guidelines](http://circ.ahajournals.org/content/114/7/e257.full))\n\n## Background\n\n**Atrial Fibrillation** (AF) = **5x** risk for CVA and increases with age \n\n-   Patients with persistent and paroxysmal atrial fibrillation should be treated the same when it comes to deciding about anticoagulation. They have an equivalent risk of stroke.\n\n**Stroke risk factors for patients with AF: **\n\n-   Prior CVA or TIA\n-   HTN\n-   Age ≥75\n-   CHF\n-   Poor LV function\n-   DM\n\n## CHADS2 stroke risk stratification scheme \n\n-   **C** = Congestive heart failure (1 pt)\n-   **H** = Hypertension (1 pt)\n-   **A **= Age ≥ 75 (1 pt)\n-   **D **= DM (1 pt)\n-   **S2** = prior Stroke or TIA (2 pts)\n\n![](https://d2p53dh3qxfm0x.cloudfront.net/uploads/img/1jx/5/m/41833411-397e-52ca-866b-0fe62dacc52e/640.png)\n([Gage et al., JAMA, 2001](https://www.ncbi.nlm.nih.gov/pubmed/?term=11401607))\n\n## References\n\n-   [ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation](http://circ.ahajournals.org/content/114/7/e257.full)\n-   [Waldo AL. Anticoagulation: Stroke Prevention in Patients with Atrial Fibrillation. Cardiol Clin 2009; 27:125-35.](https://www.ncbi.nlm.nih.gov/pubmed/?term=19111769)\n-   [Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001 Jun 13;285(22):2864-70.](https://www.ncbi.nlm.nih.gov/pubmed/?term=11401607)\n"}}